எட் டுல்யாக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from எட் டுல்யாக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In எட் டுல்யாக் Today - Breaking & Trending Today

Fate Therapeutics Inc (FATE) Q1 2021 Earnings Call Transcript


Operator
Good day, ladies and gentlemen and welcome to the Fate Therapeutics First Quarter 2021 Financial Results Conference Call. This call is being webcast live on the Investors section of Fate Therapeutics website at fatetherapeutics.com. [Operator Instructions]
I will now turn the call over to Scott Wolchko, President and CEO of Fate Therapeutics. Scott, you may begin.
Scott Wolchko
President And Chief Executive Officer
Thank you. Good afternoon and thanks everyone for joining us for the Fate Therapeutics first quarter 2021 financial results call. Shortly after 4:00 p.m. Eastern Time today, we issued a press release with these results, which can be found on the Investors section of our website under Press Releases. In addition, our Form 10-Q for the quarter ended March 31, 2021 was filed shortly thereafter and can be found on the Investors section of our website under Financial Information. Before we begin, I would like to remind everyone that except for ....

United States , Robyn Karnauskas , Jeff Miller , Ted Tenthoff Piper Sandler , Alethia Young Cantor , Sarah Cooley , Alethia Young , Wayne Chu , Michael Yee , Peter Lawson , Edward Dulac , Yigal Nochomovitz , Scott Wolchko , Piper Sandler , Bob Valamehr , Sloan Kettering , Ed Dulac , Robyn Karnauskas Truist , Michael Yee Jefferies , Ted Tenthoff , Peter Lawson Barclays , Yigal Nochomovitz Citi , Development Officer , American Society Of Clinical Oncology Annual Meeting , Fate Therapeutics Inc , American Society Of Gene ,

Fate Therapeutics Inc (FATE) Q4 2020 Earnings Call Transcript


Operator
Welcome to the Fate Therapeutics Fourth Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section on Fate s website at fatetherapeutics.com. As a reminder, today s call is being recorded.
I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics. The floor is yours.
Scott Wolchko
President and Chief Executive Officer
Thank you. Good afternoon, and thanks everyone for joining us for the Fate Therapeutics fourth quarter 2020 financial results call. Shortly after 4:00 P.M. Eastern Time today, we issued a press release with these results, which can be found on the Investor section of our website under Press Releases. In addition, our Form 10-K for the year ended December 31, 2020 was filed shortly thereafter and can be found on the Investor section of our website under Financial Information. ....

United States , Robyn Karnauskas , Matt Biegler , Alethia Young Cantor , Alethia Young , Michel Sadelain , Wayne Chu , Peter Lawson , Matt Biegler Oppenheimer , Yigal Nochomovitz , Nick Abbott , Ibanez Ventoso , Mara Goldstein , Ben Burnett , Scott Wolchko , Mara Goldstein Mizuho , Bob Valamehr , Sloan Kettering , Ed Dulac , Michael Schmidt Guggenheim , Srikripa Devarakonda Truist , Biren Amin , Biren Amin Jefferies , Michael Schmidt , Peter Lawson Barclays , Ibanez Ventoso Stifel ,